MedPath

LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION, USP 4%

Approved
Approval ID

6f79a974-6d8f-480a-93be-1b4bea1cf603

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 28, 2023

Manufacturers
FDA

Wockhardt USA LLC.

DUNS: 170508365

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

lidocaine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64679-465
Application NumberANDA087881
Product Classification
M
Marketing Category
C73584
G
Generic Name
lidocaine hydrochloride
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 28, 2023
FDA Product Classification

INGREDIENTS (5)

PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
LIDOCAINE HYDROCHLORIDEActive
Quantity: 40 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIDOCAINE HYDROCHLORIDE - FDA Drug Approval Details